Introduction 1
Progress has been made in antibody engineering technology in the last decade, 2 which has enabled the production of recombinant antibodies including chimeric, 3 humanized and human antibodies. Different systems to produce recombinant antibodies 4 have been developed and used, such as bacterial (Bird et al., 1988) , yeast (Davis et al., 5 1991) , insect (Bei et al., 1995; Hasemann and Cappa, 1990) , mammalian (Jost et al., 6 1994) , transgenic plant (Whitelam et al., 1994) and animal methodologies (Pollock et al., 7 1999) . In order to obtain recombinant antibodies capable of full activity, expression in 8 eukaryotic cells has been preferred over bacterial systems that often produce insoluble 9
antibodies that remain inactive even after re-folding. Insect cells infected with 10 recombinant baculovirus have been used for the high-level expression of antibodies 11 (Hasemann and Cappa, 1990; Verma et al., 1998) , because they are capable of a similar 12 post-translational modification to that occurring in mammalian cells, and also because 13 of the high expression levels achievable. Recombinant baculoviruses are used to infect 14 insect cells, Sf9 and High Five cells, and recombinant antibodies are recovered from the 15 infected cells. However, to improve the yield of recombinant antibodies, optimization of 16 the reactor performance, reactor design and the development of appropriate media are 17 still required. For example, the serial passage and preparation of large amounts of 18 recombinant baculovirus for the infection of insect cells are major drawbacks when 19 using baculovirus-insect cell expression systems. 20 human Ig Cλ sequence DNA from pUC18/human IgCλ was amplified using primers 1 Clambda-F and Clambda -R. PCR was performed using the following program: 3 min at 2 95 o C, 35 cycles at 95 o C for 15 s, 55 o C for 30 s and 68 o C for 1 min, followed by a final 3 extension at 68 o C for 5 min. All of the amplified PCR fragments were purified using a 4 GFX PCR purification kit (Biocompare Inc., San Francisco, CA) and stored at -20 o C for 5 subsequent cloning. 6 7
Construction of recombinant BmNPV bacmids 8
The recombinant BmNPV bacmid for IgG1 expression was constructed as follows 9 (Fig. 1) . Xho I-and Nco I-digested 29IJ6VL, and Nco I-and Kpn I-digested Cλ 10 fragments were ligated into Xho I and Kpn I digested pFastBac Dual (Invitrogen) 11 fragments using T4 ligase (pFastBac Dual/29IJ6VL-Cλ). Bam HI-and Eco RI-digested 12 29IJ6VH and Eco RI-and Pst I-digested γ1 fragments were ligated into Bam HI and 13
Pst I digested pFastBac Dual/29IJ6VL-Cλ using T4 ligase (pFastBac Dual/29IJ6 IgG). 14 Expression of the 29IJ6 IgG1 gene is controlled by a polyhedrin promoter in the 15 pFastBac Dual/29IJ6 IgG, but that of the 29IJ6 lambda chain gene is controlled by a p10 16 promoter. To secrete expressed protein(s) into the silkworm larval hemolymph, the 17 signal sequence from bombyxin (bx) was added to both the heavy and the light chain 18 genes. In order to decrease the proteolytic degradation of expressed 29IJ6 IgG, a 19 cysteine protease-and chitinase-deficient Bombyx mori multiple nucleopolyhedrovirus 20 (BmNPV-CP --Chi -) bacmid (Park et al., 2008) was used. The pFastBac Dual/29IJ6 IgG 21 was then transformed into each E. coli DH10BacBm-CP --Chi -, cultivated in a LB (10 g 1 of tryptone, 5 g of yeast extract, 10 g of NaCl, and 20 g of agar per liter) plate 2 containing 50 μg/ml kanamycin, 7 μg/ml gentamycin, 10 μg/ml tetracycline, 100 μg/ml 3 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) and 40 μg/ml isopropyl 4 β-D-1-thiogalactopyranoside (IPTG). White colonies were selected, and positive clones 5 harboring the BmNPV bacmid were used for expressing the IgG1, and the white colony 6 was picked up as positive clones. 7 8
29IJ6 IgG expression in harvested silkworm larvae and hemolymph 9
BmNPV bacmid DNA was injected directly into larvae on the first day of their 10 fifth-instar. Four μg of both BmNPV bacmid and the helper plasmid pMON7124 DNA 11 were suspended in 5 μl of 1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl 12 ammonium bromide (DMRIE)-C reagent (Invitrogen) and left to stand at room 13 temperature for 45 min. The resultant mixture was diluted to a final volume of 50 μl 14 with PBS, and 20 μl of the mixture was then injected into the dorsum of the larvae using 15 a syringe with a 26-gauge beveled needle. Expression of IgG in the silkworm larvae was 16 confirmed at 6 days post-injection (d.p.i.). 17
Silkworm larvae at 6 d.p.i. during the fifth instar were bled by cutting the 18 abdominal legs with scissors. Hemolymph was immediately mixed with 5 μl of 200 mM 19 1-phenyl-2-thiourea, and centrifuged at 9000 rpm for 10 min at 4 o C. The supernatant 20 samples were immediately frozen at -80 o C for further analysis. 21
SDS-PAGE, Western blot, and lectin blot analyses 1
The protein content in the hemolymph was examined using sodium dodecyl 2 sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot. SDS-PAGE 3 was performed with 10% polyacrylamide gel using the Mini-protein III System 4 (Bio-Rad Laboratories, Hercules, CA, USA). The respective bands were detected using 5
Coomasie Brilliant Blue (CBB). For the Western blot, the samples were boiled for 5 6 min before they were run on the SDS-PAGE gel. An mouse anti-human IgG (H+L) 7 antibody (Jackson ImmunoResearch Lab., Inc. West Grove, PA, USA) was used as the 8 primary antibody, and goat anti-mouse IgG-horseradish peroxidase (GE Healthcare, 9
Piscataway, NJ, USA) (1:10,000) was used as the secondary antibody. The immunoblot 10 bands were visualized using ECL plus Western blotting detection reagents (GE 11 Healthcare), and analyzed using a Fluor-S/MAX multi-imager (Bio-Rad). Magic Mark 12 XP Western Protein Standard (Invitrogen) was used as a protein molecular weight 13 marker. 14 Proteins were transferred to the SDS-PAGE as described above. The gel was 15 blocked by washing three times with TBST (10 mM TrisHCl, pH, 7.4, 150 mM NaCl, 16 0.05% Tween 20) for 10 min. It was then incubated with FITC-conjugated lectin for 1 h 17 at room temperature, followed by three washes with TBST for 5 min. The lectins used 18
were Concanavalin A (ConA), and agglutinins from Lens culinaris (LCA), Arachis 19 hypogaea (PNA), wheat germ (WGA), Aleuria aurantia (AAL) and Sambucus 20 sieboldiana (SSA). The signal was analyzed using a Fluor-S/MAX multi-imager 1 (Bio-Rad). 2
The protein concentration was measured using a Bradford protein assay kit 3 (Bio-Rad), with BSA as a standard. 4
Quantification of 29IJ6 IgG and antigen binding 5
The expressed IgG in silkworm larvae was quantified using the Human IgG ELISA 6 quantification kit (Bethyl Lab. Inc., Montgomery, TX, USA). One hundred μl/well of 7 10-μg/ml goat anti-human IgG-affinity purified solution was used as a coating antibody 8 in a coating buffer containing 0.05 M carbonate-bicarbonate (pH 9.6). This was used to 9 coat a 96-well flexible assay plate for 1 h at room temperature. Two hundred μl of 10 blocking solution (10% skimmed milk in 50 mM Tris-HCl 0.14 M NaCl, pH 8.0) was 11 added to the antibody-coated plate wells, followed by incubation for 30 min at room 12 temperature. The wells were washed three times with a washing solution (50 mM 13
Tris-HCl 0.14 M NaCl, 0.05% Tween 20, pH 8.0) and the diluted expressed protein was 14 then added to the antibody-coated plate wells, incubated for 1 or 2 h at room 15 temperature and washed three times with 200 μl of washing buffer. As a second 16 antibody, 100 μl of goat anti-human IgG-HRP conjugate diluted 50,000-100,000 times 17 in sample/conjugate diluent (50 mM Tris-HCl, 0.14 M NaCl, 1% BSA, 0.05% Tween 20, 18 pH 8.0), was added to each well, incubated for 1 h and washed three times with 200 μl 19 of washing buffer. 100 μl of substrate (0.1 mg/ml 3,3',5,5'-tetramethylbenzidine 20 (TMBZ) in 100 mM sodium acetate, pH 6.0, with 0.2% (v/v) of 30% hydrogen 21 peroxidase) was added to each well and left at room temperature for blue color 1 development. The reaction was stopped by the addition of 50 μl of 2 M H 2 SO 4 solution. 2
The color developed was measured at optical densities (ODs) of 450 and 655 nm. The 3 value calculated by subtracting OD 450 from OD 655 was used as a measure of the amount 4 of 29IJ6 IgG. Human reference serum (4 mg/ml) was used for the calibration of IgG as a 5 standard. 6
The antigen binding assay was performed as follows. One hundred μl/well of 10 7 μg/ml BSA was used to coat a 96-well flexible assay plate for 1 h at room temperature. 8
Two hundred μl of 20% skimmed milk in phosphate-buffered saline-Tween (PBST) 9 buffer (137 mM NaCl, 10 mM sodium phosphate, 2.7 mM KCl and 0.1% Tween 20, pH 10 7.4) was added to the BSA-coated plate wells for blocking, followed by incubation for 1 11 h at room temperature. The wells were washed three times with PBST buffer. One 12 hundred μl/well of diluted hemolymph (diluted 400-800 times) or purified 29IJ6 IgG 13 (diluted 10-200 times) were then added to the BSA-coated plate wells, incubated for 1. with a buffer (20 mM sodium phosphate, 0.5 M NaCl, pH 7.0) and mixed with 40% 2 saturated ammonium sulfate (pH 7.0) by vigorous stirring for 1.5 h. All subsequent 3 procedures were performed at 4 o C. The preparation was centrifuged at 15000 rpm for 30 4 min, and the supernatant was mixed with 50% saturated ammonium sulfate (pH 7.0) for 5 1.5 h and then centrifuged again. Subsequently the resulting supernatant was mixed with 6 70% saturated ammonium sulfate using the similar procedure as above. Each precipitate 7 was suspended with 20 mM sodium phosphate, pH 7.0, followed by dialysis against 20 8 mM sodium phosphate overnight. The dialyzed sample was applied at a flow rate of 0.5 9 ml/min to a HiTrap rProtein A FF 1 ml column (GE Healthcare) according to the 10 manufacturer's protocol. The column was then subsequently eluted at 0.5-1 ml/min with 11 elution buffer (0.1 M sodium citrate, pH 3.0). Six ml of the eluate from the column was 12 dialyzed with 1 liter of distilled water overnight, and a 15 ml dialyzed sample was 13 obtained. The sample was lyophilized for 72 h. 14 To compare the recovery yield of recombinant IgG, the ammonium sulfate 15 purification step was omitted and a sample of hemolymph diluted 10 times was applied 16 directly to a HiTrap rProtein A FF 1 ml column using the same protocol as described 17 above. 18
Characterization of oligosaccharides by the HPLC mapping method 19
The experimental procedures used, including the chromatographic and mass 20 spectrometric conditions, have been described previously (Nakagawa et al. 1995 ; 21 1 preparation of the 2-aminopyridine derivatives of the N-glycans. The purified IgG (0.3 2 mg) was digested with PNGaseF (New England Biolabs, MA, USA) to release 3 N-glycans. After removal of the peptide materials by SepPack reversed-phase cartridges 4 (Waters, MA, USA), the reducing ends of the N-glycans were derivatized with 5 2-aminopyridine (Wako, Osaka, Japan). This mixture was applied to a DEAE column 6 (Tosoh, Tokyo, Japan) or a TSK-gel Amide-80 column (Tosoh), and then each fraction 7 separated on the amide column was applied to a Shim-pack HRC-ODS column 8 (Shimadzu, Kyoto, Japan). The elution times of the individual peaks onto the 9 amide-silica and ODS columns were normalized with respect to the degree of 10 polymerization of 2-aminopyridine-derivatized (PA-) isomalto-oligosaccharide, and 11 represented in units of glucose (GU). Thus, a given compound from these two columns 12 provided a unique set of GU values, which corresponded to coordinates on the HPLC 13 map. The PA-oligosaccharides were identified by comparison with the coordinates of 14 around 500 reference PA-oligosaccharides in a home-made web application, GALAXY 15 (Takahashi et al. 2003) . The matrix assisted laser desorption/ionization time of the 16 PA-oligosaccharides was assessed by flight mass spectrometry (MALDI-TOF-MS) and 17 co-chromatography with reference to PA-oligosaccharides on the columns was used to 18 confirm their identities. 19 20
Results 21
BmNPV-CP --Chi -/29IJ6 IgG with bx signal peptides was constructed for the 2 secretion of 29IJ6 IgG into silkworm larval hemolymph which was sampled at 6 d.p.i. 3
and subjected to Western analysis. The secretion of heavy and light chains in the 4 hemolymph was confirmed ( Fig. 2A, lane 2) , and their predicted molecular weights 5 were 52 and 26 kDa, respectively. The H 2 L 2 antibody assembled was also observed in 6 its non-reduced condition ( Fig. 2A, lane 4) , which suggests that heterodimerization does 7 occur in the hemolymph. No band was observed from mock-injected silkworm larval 8 hemolymph ( Fig. 2A, lanes 1 and 3) . The average amount of 29IJ6 IgG obtained was 9 46.1±10 μg/ml corresponding to 36.9±8.1 μg/silkworm larva (Fig. 2B) . 10
Purification of the recombinant 29IJ6 IgG expressed in silkworm larval hemolymph 11
The hemolymph diluted 10 times and containing 188.9 μg of 29IJ6 IgG 12 (0.81 μg/mg protein) was precipitated with 50% sodium sulfate and dialyzed against 13 distilled water. In this fraction, 99.8 μg of 29IJ6 IgG (0.92 μg/mg protein) was obtained 14 with a yield of 52.8%. This amount was subjected to a HiTrap rProtein A FF column, of 15 which 25 μg (0.21 μg/mg protein) was found to be flow-through and 68.4 μg 16 (118.8 μg/mg protein) was eluted with a yield of 36.2%. The eluted sample was 17 subjected to an antigen binding assay, and no differences between samples were found 18 (data not shown). 19
To improve the purification yield, the sample diluted 10 times was filtered through 20 a 4.5 μm Millipore filter and subjected directly to the HiTrap rProtein A FF column. 21
Protein A column chromatography removed most of the larval protein as demonstrated 1 by the Coomassie-stained SDS-PAGE gel run under reducing conditions (Fig. 3A, lane  2   6 ). This simple purification resulted in the production of 350 μg of recombinant IgG 3 with an increase in purity from 1.3 μg per mg total protein in the crude larval 4 hemolymph ( Table 2 ). The estimated total recovery was 83.1% (6.6 mg/kg larva). 5
The functional activity of recombinant 29IJ6 IgG was demonstrated by ELISA 6 using the purified 29IJ6 IgG and larval hemolymph, which were compared for their 7
antigen binding with anti-human IgG-Fc-HRP antibody. Typical profiles of both 8 samples are shown in Fig. 3B . The working range of the 29IJ6 IgG was from 1 to 100 9 ng. The calculated 50% saturation values were between 7 and 10 ng for both samples, 10 suggesting that no significant inactivation of recombinant IgG occurred during the 11 purification step. 12 The reactivity of recombinant 29IJ6 IgG with various lectins was examined (Fig. 4) . 16
The ConA lectin reacted with recombinant 29IJ6 IgG, indicating the presence of a 17 non-reducing terminal α-mannosyl group (Fig. 4) . In addition, the reaction with LCA 18 lectin suggested the presence of an α 1-6 fucose residue attached at the reducing 19 terminus. Similarly, reactions with AAL, PNA and WGA lectins indicated the presence 20 of α-Fuc1-6GlcNAC, Galβ1-3GlcNAc disaccharide of O-glycans, and GlcNAc, 21 respectively. Conversely the SSA lectin, known to recognize Siaα2-6Gal, did not react 1 with recombinant 29IJ6 IgG, suggesting that sialic acid was absent. The lectin binding 2 properties are summarized in Table 3 . 3
The structures of the N-linked glycans were determined by comparing their 4 positions with those of known standard oligosaccharides on a two-dimensional map. 5
Identification of a sample PA-oligosaccharide was confirmed by co-chromatography 6 with a known PA-oligosaccharide on the ODS and amide-silica columns. The detailed 7 chromatogram and structure of the oligosaccharides are shown in Fig. 5 . The 8 recombinant 29IJ6 IgG antibody had a non-reducing terminal α-mannosyl group 9 lacking sialic acid, whilst fucose was connected to GlcNAc near Asn. Non-reducing 10 terminal α-mannosyl sugars were calculated to account for 90.2% of the total sugar 11 content and included 12.7% antennary sugars. PNA lectin showed the possible 12 attachment of Galβ1-4GlcNAc, which may be Galβ1-4GlcNAcβ1-2Manα1-. This 13 unidentified oligosaccharide might be included with others (9.8%) in Fig. 5B.  14 
Discussion 15
In this study, a model human IgG1 was expressed in silkworm larval hemolymph. 16
The amount of IgG secreted from the larvae was 46 μg/ml, which is higher than that 17 obtained using insect cells where the expression level of secreted human HAV16 18 antibody using High Five insect cells was reported at around 6-18 μg/ml (Liang et al., 19 2001 ). In another study, multiple-protease-deficient strains of the methylotrophic yeast 20
Ogataea minuta secreted 10 μg/ml of antibody, where the partial degradation of 21 antibody was suppressed (Kuroda et al., 2007) . CHO-DG44 cells from mammals have 1 been reported to produce 35 μg/ml of monoclonal antibody against botulinum 2 neurotoxin serotype A (Mowry et al., 2004) . Although the specificity varied between 3 antibodies, comparison with these other experiments demonstrates that silkworm larvae 4 are a potential host capable of expressing a comparable or superior level of human IgG. 5
However, a larger amount of antibody can be produced using transgenic animals. For 6 example, 4 g/l and 14 g/l of hBR96-2, a humanized IgG1, were recorded in the milk of 7 transgenic mice and goats, respectively (Pollock et al., 1999) . However, these authors 8 also reported that the other female founder produced only low levels (0.1 g/l) of 9 antibody, which suggests that significant fluctuations in antibody production occur in 10 transgenic animals. The N-glycans on 29IJ6 IgG produced in the silkworm larvae were composed 1 exclusively of two kinds of paucimannose-type oligosaccharides, 2
Manα1-6Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc and 3
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc. These patterns contained 4 fucose α1,6-linked to the innermost GlcNAc residue. Misaki et al. (2003) reported the 5 presence of Manα1-6Manβ1-4GlcNAcβ1-4GlcNAc (6.4%) and 6
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc (1.1%) in N-linked glycan 7 structures of mouse interferon-β produced by Bombyx mori larvae. 8
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc may be derived from 9
GlcNAcMan 5 GlcNAc 2 through mannosidase-mediated excision of α-linked mannosyl 10 residues, followed by GlcNAcase-mediated deletion of a β-1,2-linked terminal GlcNAc 11 residue (Watanabe et al., 2002) . Likewise mannosidase-mediated excision of α-linked 12 mannosyl residues from Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc 13 may lead to Manα1-6Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc. Shinkawa et al. (2003) Trends Glycosci. Glycotech. 15, [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] Takahashi, N., Nakagawa, H., Fujikawa, K., Kawamura, Y., Tomiya, N., 1995. 19 Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl 20 oligosaccharides. Anal. Biochem. 226, [139] [140] [141] [142] [143] [144] [145] [146] Verma, R., Boleti, E., George, A.J., 1998 Man, mannose; Fuc; fucose; Gal, galactose; GlcNAc, N-acetyl glucosamine; Sia, sialic acid 3 
